The Economic Burden of Dysphagia in Hong Kong Healthcare
Dysphagia is not simply a clinical problem — it is a substantial economic one. Its consequences, when unmanaged or under-managed, cascade across the healthcare system: aspiration pneumonia drives acute admissions, prolonged hospital stays consume ward capacity, malnutrition increases complication rates, and repeat hospitalisations create long-term cost spirals. Yet formal health economic analyses of dysphagia in Hong Kong are rare, leaving policymakers and planners without the data needed to justify investment in prevention and early intervention.
This page synthesises available Hong Kong-specific data and applies international evidence to estimate the economic burden of dysphagia in the local healthcare context.
Framework: How Dysphagia Generates Healthcare Costs
The economic impact of dysphagia operates through several pathways:
- Aspiration pneumonia: The most costly direct complication — requires acute hospitalisation, antibiotics, potential ICU admission, and extended stay
- Malnutrition and dehydration: Poor nutritional intake increases infection risk, delays wound healing, and prolongs recovery
- Extended hospital length of stay: Unmanaged dysphagia delays discharge readiness, increasing bed-days consumed per episode
- Tube feeding costs: Nasogastric (NGT) and percutaneous endoscopic gastrostomy (PEG) tubes impose procedural, consumable, and monitoring costs
- Readmission cycles: Patients discharged without adequate swallowing management are frequently readmitted
- Care home escalation: Dysphagia-related deterioration drives transfers from community to residential and then higher-dependency care levels
- Productivity loss: Family caregivers spend significant time managing mealtime assistance and care coordination
Aspiration Pneumonia: The Dominant Cost Driver
Global Evidence
Aspiration pneumonia is consistently identified as the largest single cost component of dysphagia-related healthcare expenditure in international studies.
In the United States, Altman et al. (2010) analysed a national inpatient database and found that patients with dysphagia had 40% longer hospital stays and 39% higher hospital costs compared to matched controls without dysphagia. Aspiraton pneumonia admissions cost an average of USD $17,000–$25,000 per episode (2010 USD).
A 2019 systematic review by Attrill et al. (Australian context) found that dysphagia added an average of AUD $4,400–$6,200 per acute hospitalisation, predominantly through extended length of stay attributable to aspiration pneumonia management.
Hong Kong Estimates
The Hospital Authority does not publish granular dysphagia-specific cost data. However, several data points allow estimation:
HA bed-day cost: The HA’s cost recovery data indicates that the average daily bed cost in an acute public hospital ranges from approximately HKD $6,000 (general ward) to HKD $20,000+ (ICU). A conservative estimate of HKD $7,000 per acute ward day is used below.
Aspiration pneumonia length of stay: A retrospective analysis from Queen Mary Hospital (Ha et al., 2019, internal report) found a mean LOS of 14.2 days for aspiration pneumonia admissions, compared to 7.8 days for community-acquired pneumonia. Aspiration pneumonia admissions thus consume, on average, approximately 6.4 additional bed-days.
Additional cost per aspiration pneumonia admission: 6.4 days × HKD $7,000 = approximately HKD $44,800 per admission above baseline pneumonia cost.
Estimated annual admissions: If aspiration pneumonia accounts for approximately 20% of the estimated 30,000–40,000 pneumonia admissions annually in Hong Kong (based on the Shum et al. estimate referenced in the epidemiology page), this implies 6,000–8,000 aspiration pneumonia admissions per year.
Gross annual aspiration pneumonia bed cost estimate: 7,000 admissions × HKD $44,800 incremental cost = approximately HKD $313 million per year in excess bed-days attributable to aspiration pneumonia versus general pneumonia. This is a conservative floor — it does not include ICU admissions, readmissions within 30 days, or downstream care escalation costs.
Tube Feeding Costs
Patients who cannot safely swallow often require enteral nutrition support — either nasogastric (NGT) or, for long-term cases, percutaneous endoscopic gastrostomy (PEG).
NGT placement and management: NGT insertion is a routine nursing procedure, but associated costs include tube sets, feeding formula (standard liquid feeds cost approximately HKD $150–300/day in public hospital contracts), dietitian monitoring, and radiology confirmation for displaced tubes.
PEG insertion: PEG is an endoscopic procedure performed under sedation. HA procedure costs are not publicly disaggregated, but comparable health system benchmarks suggest HKD $15,000–25,000 for the procedure plus inpatient monitoring.
Long-term PEG maintenance: Community or care home PEG patients require regular nursing monitoring, formula supply, and periodic gastroenterology review. Annual ongoing cost per PEG patient is estimated at HKD $30,000–50,000 including consumables and professional input.
The HA does not publish PEG insertion rates, but a conservative estimate of 1,500–2,500 new PEG insertions annually (based on a ratio to stroke volume and terminal illness patterns) implies a gross procedure cost of HKD $22–62 million annually, plus ongoing maintenance costs for the prevalent PEG-dependent population.
Malnutrition Cost Amplification
Dysphagia frequently causes or worsens malnutrition. Malnourished hospitalised patients have consistently worse clinical outcomes, including:
- Higher rates of surgical and medical complications
- Longer length of stay (meta-analyses suggest 3–5 additional days per malnourished patient)
- Higher rates of healthcare-associated infection
- Greater 30-day and 90-day readmission rates
A 2020 analysis by the Nutrition Business Journal (extrapolated to Asian settings) estimated that hospital malnutrition adds approximately USD $4,000–$8,000 per episode in excess costs. The proportion of this attributable to dysphagia-related intake reduction versus other causes is difficult to isolate, but in geriatric and neurological populations, dysphagia is a primary contributing factor.
Readmission Costs
Patients discharged with unmanaged or inadequately managed dysphagia face high 30-day readmission rates. International evidence suggests 30-day all-cause readmission rates of 20–35% for elderly patients with aspiration pneumonia — significantly higher than for matched non-dysphagia pneumonia patients (12–18%).
Each readmission carries full acute admission costs. At HKD $7,000/day and an average LOS of 10 days per readmission, each aspiration pneumonia readmission costs approximately HKD $70,000. Even a 5% reduction in the readmission rate across 7,000 aspiration pneumonia admissions would save approximately HKD $24.5 million per year.
Care Home Escalation Costs
Dysphagia that is not managed appropriately at the care home level tends to drive patients toward higher-dependency settings — from residential care homes to nursing homes to acute hospitalisation. Each step up the care ladder carries substantially higher per-diem costs:
| Care setting | Approximate cost per day (HKD) |
|---|---|
| Home with community support | 200–500 |
| Residential care home (RCHE) | 500–900 (subsidised) |
| Care and attention home (C&A) | 900–1,500 |
| Nursing home | 1,500–3,000 |
| Acute hospital ward | 6,000–8,000 |
| ICU | 20,000+ |
Effective dysphagia management that keeps patients stable at the RCHE/C&A level rather than escalating to nursing home or acute admission generates significant cost savings. A hypothetical 10% reduction in escalation from C&A to nursing home for 5,000 patients with significant dysphagia would save approximately HKD $200–400 million annually at nursing home vs. C&A cost differentials — though this estimate carries wide uncertainty.
Investment Case for Dysphagia Prevention
The data above suggest a compelling investment case for systematic dysphagia prevention and management:
Speech-Language Pathology staffing cost: An additional SLP in the public sector costs approximately HKD $500,000–700,000 annually (salary and on-costs). A single SLP managing 100–150 patients per year, reducing one aspiration pneumonia readmission per patient, saves approximately HKD $7 million in readmission costs — a return of 10:1 or better.
Care home staff training: A structured dysphagia awareness and mealtime assistance training programme for frontline care workers costs approximately HKD $2,000–5,000 per worker. If training prevents one aspiration pneumonia hospitalisation per 10 trained workers, the break-even threshold is easily met.
IDDSI implementation in care homes: Standardising texture modification reduces waste, improves nutritional intake, and reduces adverse events. Case studies from Australian aged care suggest one-time implementation costs of AUD $5,000–15,000 per facility, with sustained annual savings through reduced adverse events.
Data Gaps and Research Recommendations
Formal health economic analysis of dysphagia in Hong Kong is overdue. Priority research questions include:
- A territory-wide audit of aspiration pneumonia admissions with dysphagia coding — to establish a baseline incidence and cost figure
- A prospective cohort study linking dysphagia diagnosis to 90-day outcomes (readmission, aspiration pneumonia, malnutrition, mortality) in the public hospital system
- A cost-effectiveness analysis of early SLP intervention versus usual care in acute stroke patients with dysphagia
- An economic evaluation of IDDSI implementation across HA-linked care homes
Without this data, dysphagia will remain under-resourced relative to its actual economic and clinical burden.
This analysis is intended for healthcare planners, policymakers, and clinical administrators. All figures are estimates based on available public data and international benchmarks. For clinical management guidance, see the For Professionals page.